source
- Lawmakers push FDA to close loophole allowing import of counterfeit Eli Lilly obesity drugA bipartisan group of U.S. lawmakers is urging the Food and Drug Administration to address a regulatory gap that permits the importation of unapproved versions of retatrutide, an experimental obesi…
- Lycia Therapeutics targets $228M IPO to fund food allergy protein degrader programsLycia Therapeutics announced plans for an initial public offering expected to raise about $228 million. The proceeds are intended to support its pipeline of protein degrader therapeutics targeting…